Sato Tomohiko, Goyama Susumu, Nitta Eriko, Takeshita Masataka, Yoshimi Mayumi, Nakagawa Masahiro, Kawazu Masahito, Ichikawa Motoshi, Kurokawa Mineo
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Cancer Sci. 2008 Jul;99(7):1407-13. doi: 10.1111/j.1349-7006.2008.00842.x. Epub 2008 Apr 29.
Evi-1 is a zinc-finger transcriptional factor whose inappropriate expression leads to leukemic transformation in mice and humans. Recently, it has been shown that Evi-1 regulates proliferation of hematopoietic stem/progenitor cells at embryonic stage via GATA-2 up-regulation; however, detailed mechanisms underlying Evi-1-mediated early hematopoiesis are not fully understood. We therefore evaluated hematopoietic potential of Evi-1 mutants using a cultivation system of murine para-aortic splanchnopleural (P-Sp) regions, and found that both the first zinc finger domain and the acidic domain were required for Evi-1-mediated hematopoiesis. The hematopoietic potential of Evi-1 mutants was likely to be related to its ability to up-regulate GATA-2 expression. We also showed that the decreased colony forming capacity of Evi-1-deficient P-Sp cells was successfully recovered by inhibition of TGF-b signaling, using ALK5 inhibitor or retroviral transfer of dominant-negative-type Smad3. Our findings suggest that Evi-1 promotes hematopoietic stem/progenitor expansion at the embryonic stage through up-regulation of GATA-2 and repression of TGF-beta signaling.
Evi-1是一种锌指转录因子,其异常表达会导致小鼠和人类发生白血病转化。最近研究表明,Evi-1通过上调GATA-2在胚胎期调节造血干/祖细胞的增殖;然而,Evi-1介导早期造血的详细机制尚未完全明确。因此,我们使用小鼠主动脉旁脏壁层(P-Sp)区域培养系统评估了Evi-1突变体的造血潜能,发现Evi-1介导的造血过程需要第一个锌指结构域和酸性结构域。Evi-1突变体的造血潜能可能与其上调GATA-2表达的能力有关。我们还表明,使用ALK5抑制剂或显性负型Smad3的逆转录病毒转导抑制TGF-β信号传导,可成功恢复Evi-1缺陷型P-Sp细胞降低的集落形成能力。我们的研究结果表明,Evi-1通过上调GATA-2和抑制TGF-β信号传导在胚胎期促进造血干/祖细胞扩增。